McDermott, D. F., Signoretti, S., Lee, J. L., Donskov, F., Tykodi, S. S., Tomczak, P., Bjarnason, G. A., Larkin, J. M., Kochenderfer, M. D., Gafanov, R., Cristescu, R., Zhang, Y., Chuang, C., Chen, C., Rodriguez-Lopez, K., Pena, C. E., Perini, R. F., Atkins, M. B. (2026). Circulating tumor DNA (ctDNA) analysis in participants (pts) with advanced clear cell renal cell carcinoma (ccRCC) treated with first-line pembrolizumab (pembro) monotherapy from the phase 2 KEYNOTE-427 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.541